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Application of hydroxyapatite as a biomaterial in tissue engineering is challenging by its issue 
on stability. Hence, the capability of silica aerogel in improving the stability and 
biocompatibility of hydroxyapatite was proposed. Silica aerogel attracts much interest in 
various applications ranging from construction to medicine because of its excellent properties. 
This review summarizes the potential of hybrid silica aerogel in biomedical applications in 
regards to its different compositions. The review covers recent and previous studies on the 
hybrid silica aerogel, either organic or inorganic which are biocompatible to human cells. The 
future perspective focusing on the potential of hydroxyapatite incorporated silica aerogel as a 
biomaterial is also discussed here. 
 





The development of bioceramic material for the application in medical science and engineering 
fields rises in the past few decades due to its biocompatibility and high stability in human body 
[1-2] . Bioceramic does not release toxic element to human body even after exposure for a long 
time [3-4]. Hydroxyapatite, Ca10(PO4)3(OH)2, (HA) which is a type of bioceramic is a common 
active material suitable for implant and widely used and studied as an alternative material for 
bone grafting [5-7]. Hydroxyapatite is a major mineral component in natural bone and because 
of this; it has excellent biocompatibility [6]. During bone remodeling, it can induce the 
generation of new bone and support bone growth which leads to the formation of a strong bond 
between hydroxyapatite and natural bone [7]. The bonding strength of the interface is so high 
that the bone fracture is usually generated within the hydroxyapatite structure. The porosity of 
the hydroxyapatite contributes to a mechanical interlock which could lead to a stable and strong 
fixation of the material. Because of this, the strength of the hydroxyapatite implant will be 
increased with the increasing growth of bone cells inside the pores of the hydroxyapatite [8]. 
Due to this bonding interface, the bonding strength of hydroxyapatite and bone is much higher 
than other metal implants [9]. Thereby, the relative micro-movement between the implant and 




bone is dramatically reduced by this direct bonding. This is actually very crucial for the 
recovery of the patient after the implantation procedure taken place [10-11]. 
 
However, hydroxyapatite shows some drawbacks when compared with other bioactive 
materials. The drawbacks of the hydroxyapatite include naturally brittle and poor mechanical 
properties although it has high biocompatibility and bioactivity [12-13]. The maximum fracture 
toughness of hydroxyapatite is about 1.0 MPa m1/2 while the fracture toughness of human 
cortical bone ranges from 2-12 MPa m1/2 depending on the type and age of the bones [6,14]. 
The poor impact resistance and low fatigue strength limit the clinical application of this 
material. In addition, the high chemical stability of stoichiometric hydroxyapatite with body 
fluids could lead to restrict bioactivity and lowering the effects of osteoconductive [15-16]. 
This resulted in a longer rehabilitation time for the patients and thus increases the probability 
of failure due to deficient implant fixation. It is clear that hydroxyapatite cannot be used as a 
bulk material sustaining tension or impact. Therefore, in order to improve the fracture 
toughness and flexural strength of hydroxyapatite, there are various techniques could be 
applied, for instance, refining the microstructure of hydroxyapatite and incorporating 
reinforcing phases [17–19]. 
 
2.0 SILICA MODIFIED HYDROXYAPATITE 
 
Silica, or silicon dioxide (SiO2) is one of the abundant material on earth formed by silicon and 
oxygen. It can exists as its own which is not chemically bonded by other elements or it can 
combine with other elements forming silicates [20]. Silica exists in two major forms which are 
crystalline and amorphous where both of which may be derived naturally or synthetically 
produced [21]. Silica could affect human health in which the crystalline silica could give 
adverse health effects such as silicosis and possibly cancer whereas, there is still unclear effects 
of amorphous silica on human health [22–24]. It is perhaps surprising that silica is more often 
associated with humans and animals [25-26]. The normal blood level of silica in humans is 
reported less than 5 mg/L and the level of silica in organs such as brain and muscle varied 
between 2 and 10 mg/L [27-28]. The silica content of bone and other connective tissues was 
found to be much higher ranging between 12 and l00 mg/L [24,27]. In animals, silica is found 
in skin, muscle, tendon, hair and feathers [28].  
 
Silica is one of the most important element in cell growth, as it plays a role in initial 
calcification and the formation of collagen in cells and tissues [29]. The role of silica in the 
development of skeletal tissue and formation of bone has been proven by Carlisle [17] and its 
role in osseointegration has been extensively studied by other researchers [25,29-30]. In term 
of its usage for chicks’ development, silica was shown to assist the growth of feather and 
skeleton as well as production of connective tissue [31-32]. The concentration of silica in young 
growing bones was in the same range with that of calcium, phosphorus and calcium [32-33]. 
Silica has a role in bone matrix formation prior to calcium deposition where the calcium is 
replaced with silica which could happen at the stage of bone maturity progressing [25,34]. 
 
The positive effect of silica in the cell growth could cause increasing interest of 
researchers to work on silica modified hydroxyapatite as an advanced biomaterial [35]. A series 




of studies related to the incorporation of silica into hydroxyapatite structure have been reported 
[18,36, 37]. Previous studies have demonstrated that the incorporation of silica into 
hydroxyapatite significantly increase the rate of bone apposition to hydroxyapatite bioceramic 
implants [15]. Furthermore, a composite matrix of hydroxyapatite-silica core-nanorods 
enhanced vascularization in the chicken chorioallantoic membrane and enhanced new bone 
formation of critical-sized femoral segmental defect in rats [37]. The formation of new bones 
and tissues increased with the increasing silicate substitution for phosphate ions in 
hydroxyapatite [11,38]. Silica was reported to be important in enhancing the bioactivity of 
hydroxyapatite [39]. It is due to the existent of silanol groups and resorption of silica during 
treatment and cells are positively influenced by this released phenomenon [40–42]. Recent 
reports confirm that the in vivo dissolution of silica modified hydroxyapatite increased with the 
silica content and it was found to be strongly affected by the silica modified hydroxyapatite 
structure [31]. Rapid release of soluble silica from bioactive glasses leads to rapid proliferation 
of new bone within a bone defect site [18,31,43]. Other study found that the volume of unit 
cell and the parameter length of the hydroxyapatite decreased as the silica content increased 
[44]. Thus, the disorder and defect structure of silica modified hydroxyapatite offers more 
improved performances due to unusual chemical synergistic effects of the materials [38,45-
46]. The structural disorder and the microstructure defects of silica modified hydroxyapatite 
decreased the stability of apatite structure and was found to be the starting point of dissolutions 
and contributed to the higher reactivity [46–48]. The reactivity is also enhanced when silica 
exists as a tetrahedral silicate, SiO4, groups rather than in SiO2 polymeric form [25,49]. The 
tetrahedral distortion provides excellent surface for integration of osteoblast cells [50]. 
However, the incorporation of tetrahedral silicate into hydroxyapatite lattice requires high 
temperature treatment under controlled stoichiometry conditions using several precursors [51-
52]. Whereas, a high temperature treatment significantly decrease the concentrations of silanol 
groups and increase the crystallinity of hydroxyapatite [53-54]. Thus, apparently it limits the 
bioactivity of silica modified hydroxyapatite.  
 
Therefore, the sol-gel technique, which is the established technique for the synthesis of 
tetrahedral silica modified hydroxyapatite, is capable to improve various conventional 
techniques [19,34,55, 56]. Sol-gel technique is used in various applications because of its 
capability in forming pure and homogenous yield at a lower temperature [57-58]. This 
technique can control the composition and microstructure at the molecular level. In addition, 
the sol-gel technique is able to shape the materials at room temperature such as by casting bulk 
gels in the moulds, dip coating thin film or spinning fibres. Because of these advantages, the 
sol-gel technique could be an alternative technique in the conventional process of ceramic 
where the powder is designed into an object and eventually, densified at a temperature close to 
its liquids condition [59]. Dong and his coworkers [56] successfully fabricated a novel 
hydroxyapatite-chitosan-silica hybrid by combining the sol-gel method and 3D plotting 










3.0 SILICA AEROGEL 
 
A new generation of bioactive glasses has emerged in biomedical applications after silica-based 
bioactive glasses have been found and researched by Hench in 1971 [60-61]. It leads to the 
development of a wide area of research on the new silica-based bioactive materials and 
recently, the potential applications of silica-based materials have been expanded for bone tissue 
regeneration and drug delivery purposes [17]. The use of silica in medical devices is mainly 
based on the development of silica based glasses which have been found to form bonding with 
living tissues [30,33]. The immersion of silica based glasses in body fluids generates reactive 
layers on its surfaces [25,62]. These reactive layers facilitate the formation of chemical bonding 
between the glasses and the bone [63-64].  
 
According to preliminary finding by Hench [60], only composite ceramics contained 
SiO2, Na2O and CaO in a specific composition have the ability to build bonds with bone due 
to their ability in creating super-saturation Ca/P condition at surface glass and body fluid 
boundary. However, recent studies confirmed that pure silica glass which was prepared by 
hydrolysis and condensation of silicone alkoxide precursors after heat treated at 400ºC could 
also induce the formation of apatite on its surfaces upon immersion in simulated body fluid 
(SBF) [39,65]. However, the rate of apatite formation on silica glass decreased with the 
increment of heat treatment up to 900ºC [66]. Studies also showed that conventional silica glass 
which was heat treated at 900°C and dense silica glass or quartz did not exhibit any bioactivity 
after immersion in SBF [42,67]. Since the formation of apatite layer depends on silanol groups 
on silica surface, heat treated silica glass at 900°C that can reduce silanol groups on its surfaces, 
prevents the formation of apatite layers [68]. Hence, the sintering process involved in the 
synthesis of conventional silica glass can cause the reduction of silanol groups, thus lowering 
its bioactivity [58]. Therefore, it is crucial to develop a new class of pure silica gel which its 
synthesis route and its properties are compatible to human body. This is due to the finding that 
the calcination of the silica aerogel did not affect its bioactivity [69].  
 
Silica aerogel is one type of silica-based material having unique properties. It is a strong 
material and very light (Figure 1). Since its appearance is in hazy blue form and made up by 
the transparent polymer, it is often called “frozen smoke” [70]. This happen based on the 
synthesis procedure of the silica aerogel where the entrapped solvents inside the prepared wet 
gels are removed without damaging its porosity thus, making it lighter than other materials 
[71]. The synthesis procedure of silica aerogels is typically known as a sol-gel technique which 
involves hydrolysis and condensation reactions of typical source of silica which is silicon 
alkoxide in a solvent and finally, the removal of this solvent at supercritical drying stage 
[58,72]. Examples of the source of silicon alkoxide are tetramethylorthosilicate (TMOS) and 
tetraethylorthosilicate (TEOS) [72]. This synthesis procedure produced silica aerogels with 
microstructure particles that link together creating nano-sized pore and nano-particles [73]. 
 





Figure 1 Photographs of (a) before and (b) after calcination at 900°C, silica aerogel that 
synthesized from rice husk ash, on a leaf of Ficus Bonsai Tree 
 
Like other silica based material, one of the applications of the silica aerogels is an 
insulator where electric charges do not flow inside this material. It is an excellent insulator 
having low bulk density, high melting point and a low thermal conductivity [56]. Besides that, 
its pore size and volume could be tuned at the synthesis or post-synthesis stage [73]. These are 
some applications of silica aerogels: major component in ceramics, cement [35] and glass [74], 
as an adhesive agent in pharmaceuticals [75], as a catalyst [76], drug delivery system [77–79], 
as a magnetic fluorescent nanoprobe in biomedical imaging [80] and as an adsorbent for the 
removal of oil from water stream [71,81]. The overview of the types and applications of silica 
aerogels is summarized in Table 1. 
 
Table 1 Overview of various types of aerogels and their applications. 
Type of Aerogel Application Ref. 
Silica aerogels (thin films). Thicknesses from 1 
µm to 100 µm 
Electrodes, batteries 




Aluminosilicate aerogels. Specific surface area 
680 ± 10 m2/g 
 
Piezoelectric devices [83] 




Silica aerogels. Thermal expansion coefficient 4 
× 10-6 K-1 
 
Cherenkov detectors [85] 
Organic aerogels. Thermal conductivity 0.003-
0.011 W/mK 
 
Thermal superinsulators [86] 
Carbon aerogels. Density 0.07 g/cm3 
 
Solar-energy collectors [87] 









Table 1 (Cont.) Overview of various types of aerogels and their applications. 
Type of Aerogel Application Ref. 
Nanocellulose fibers-collagen composite 
aerogels. Density 0.02-0.03 g/cm3, porosity 90-
95 % 
 
Tissue engineering, wound 
dressing 
[89] 
Polysaccharide aerogels. Surface area 570 m2/g 
(calcium-cross-linked sodium alginate aerogels), 
density 0.27 g/cm3 (starch monolith aerogel), 
mesopore volume 2.6 cm3/g (Ba-alginate beads) 
 
Food-related technologies [90] 
Hydrophobic bimodal mesoporous silica 
aerogels. Surface area 1329 m2/g, pore volume 
5.3 cm3/g and pore size 19.82 nm using 
cetyltrimethyl ammonium bromide as a structure 
directing agent 
 
Green application [91] 
Copper silica aerogel catalyst.  
Surface area 836 m2/g 
Hydrogen fuel cells [76] 
 
4.0 HYBRID SILICA AEROGEL IN BIOMEDICAL APPLICATION 
 
Like other silica based materials, silica aerogels could also be applied in biomedical area 
because of its microstructure which is in amorphous state and pores in nano-sized created by 
the interconnection of their particles [92-93]. Currently, intense research works have been done 
on the applications of silica aerogels as a controlled release of drugs, peptides, enzymes and 
hormones [94–96]. The important feature of silica aerogel is its ability to host molecular size 
of particles within its network. Several works also showed that the silica aerogel is a 
biocompatible material, which can interact safely with human cells. Because of its 
biocompatible, it can be used as a scaffold to immobilize biological compounds for various 
applications as well as a matrix in the biosensor design [97-98]. One of its unique 
characteristics related to its application as a bone implant is its ability to be tuned and 
engineered so that it can stimulate the bone bioactive characteristics similar to that of 
conventional bioactive glass [57]. Silica aerogel can act as a carrier for biological active agents, 
bone substitute and drug delivery system because it can be synthesized at low temperature and 
this condition could preserve the activities of the biological and drugs compounds [99]. Besides 
that, its tetrahedral networks with silanol-rich groups make it a potential biomaterial with 
enhanced biocompatibility properties [69,100].  
 
Salinas and her colleagues [49] have successfully synthesized hybrid organic-inorganic 
silica aerogel having bone bioactive characteristics similar to the bioactive glass via sol-gel 
technique. However, the synthesized material has higher mechanical properties and also the 
elastic modulus of 72.4 MPa which is suitable for bone implant. In other works, the composite 
of silica aerogel with crosslinked dialdehyde nano-cellulose fibres and collagen could be used 




for wound dressing [89]. This was due to the properties of the composite which has 93% 
porosity, biocompatibility against fibroblast cells and also 3000% water absorption ratio. Thus, 
the hybrid organic-inorganic silica aerogel is also an alternative material for biomedical 
application. Silica aerogels were also reported to have interaction with physiological fluids. 
This resulted in the apatite layer formation similar to that of natural bone because of the 
presence of silanol group (Si-O-H) on their surfaces [50,101] and thus could lead to their 
application for bone tissue regeneration [62,102]. As a bone tissue regeneration, the unique 
properties of silica aerogels such as highly interconnectivity and porosity enhance cells 
penetration and eventually, aid the cell attachment [57]. The synthesis conditions of silica 
aerogels which is low pressure and low temperature will produce silica aerogels that are rich 
in silanol groups and it could enhance the bioactivity of the material, promote cell attachment; 
proliferation and differentiation and also exhibit controlled biodegradation or resorption rate 
simultaneous with the new tissue formation [69,95]. 
 
Study by Mallepally et al. [98] on the application of silk fibroin silica aerogel scaffolds 
as biomaterial showed the presence of human foreskin fibroblast cells in the scaffolds, as shown 
in their in vitro cytocompatibility test. Silica aerogel could increase the proliferation of the cells 
because of its unique properties where its network allows unhibitied transfer of nutrients and 
metabolic wastes. The chitin silica aerogel prepared by Ding [103] could improve the fibroblast 
cells attachment and its morphologies were maintained as compared to the control sample. This 
was due to the high surface area and porosity of the prepared material that resulted in the ability 
to adsorb liquids similar to that of extracelullar matrices. There are other types of hybrid 
aerogels that could be applied in biomedical area and they are tabulated in Table 2. 
 
Table 2 Overview of the application of hybrid aerogel in biomedical area. 
Type of Aerogel Application Ref. 
Polyurea-nanoencapsulated macroporous silica aerogels, 




Alginate-starch aerogels. BET surface 183-544 m2/g, pore 




Surface-functionalized aerogels, composite aerogels Drug delivery 
applications 
[105] 
Poly-e-caprolactone (PCL) hybrid aerogels Bone tissue 
engineering 
[106] 
Pectin-sodium montmorillonite clay-aerogel composite. 
Modulus of 114 ± 9 MPa and a specific modulus of 609 ± 





Macroporous silica aerogels. Density: 400 kg/m3, diameter 












Table 2 (Cont.) Overview of the application of hybrid aerogel in biomedical area. 
Type of Aerogel Application Ref. 
Polysaccharide aerogels. Surface area 570 m2/g (calcium-
cross-linked sodium alginate aerogels), density 0.27 g/cm3 










Polysaccharide-based aerogels. Surface area 70-680 m2/g, 








Silk fibroin aerogels. Surface area 308 m2g-1, compressive 









5.0 Hydroxyapatite Incorporated Silica Aerogel  
 
Although vast studies have been reported on the synthesis techniques and roles of silica-
substitute hydroxyapatite in bone repairing, the immobilization of hydroxyapatite in silica 
aerogel sphere matrices has so far not been reported. Owing to its nanostructure, high porosity, 
high specific surface area and extremely low thermal conductivity, silica aerogel is considered 
as an efficient system for implant application [69,102,108]. The high porous silica aerogel 
could enhanced the bioactivity of cell, bone ingrowth, mineral opposition rate and bone 
organization, as the porous structure stabilizes the interface between the material and the 
surrounding bone tissue [94-95]. Hydroxyapatite could be incorporated into silica aerogel 
tetrahedral networks (hydroxyapatite- silica aerogel) via ambient colloidal sol-gel technique 
[109]. It can be synthesized by the immersion of commercial hydroxyapatite in silica sol prior 
to the synthesis of silica aerogel [110]. Through this method, hydroxyapatite is expected to be 
incorporated in the silica aerogel network since the hydroxyapatite could be added into the 
silica sol before the gelation stage [109]. Theoretically, hydroxyapatite-sol interaction that 
established from the addition of hydroxyapatite into the sol before the aging process promotes 
the incorporation of hydroxyapatite into growing silica aerogel networks. The large number of 
non-bridging electrons available on the surface of hydroxyapatite promote an extensive weakly 
hydrogen bonding with the silicate polymer containing Si-O(H)-Si and Si-OH fragments, 
during the initial stages of the network formation [111]. This stimulates the formation of gel 
networks around the hydroxyapatite, as it acts as a template, and eventually forms a porous 
inorganic polymer cage surrounding the hydroxyapatite.  
Hydroxyapatite is expected to be easily bound to silica aerogel networks via sol-gel 
technique due to the silica-rich gel layers of silica aerogel which consists of hydroxyl groups 




[111]. A mechanically strong bonding between silica aerogel and hydroxyapatite can be 
achieved and hence, the leaching of hydroxyapatite can be avoided. It is expected that the 
diffusion resistance of cell in silica aerogel network will occur [112]. However, this effect can 
be reduced due to the open pore structure of silica aerogel and its network is in nano-sized [94]. 
The gel undergoes solvent extraction process before submitted to drying process. Thus, solvent 
extraction will avoid drastic changes of a gel texture due to the capillary stressed during the 
drying process [113-114]. In this way, its structure does not collapse and the silica aerogel 
retains its original nano-structured [115]. Thus, the silica aerogel network will be preserved 
and the interconnected pores of silica aerogel will facilitate cellular colonization and 
vascularization as well as to provide channels for tissue-fluid circulation and the removal of 
metabolic waste products. It allows cells to quickly move into the interior regions of the 
particles and subsequently interacts with hydroxyapatite [116-117]. The incorporated 
hydroxyapatite will act as guidance for bone migration and thus promoting the cells penetrating 
and growing in the materials. Hence, new bone will form a bonding at the interface and inside 
the materials, eventually it will cause a strong cell adhesion [118-119]. The reactivity of 
hydroxyapatite-silica aerogel will be improved due to the high surface area and silanol-rich 
properties of silica aerogel [58]. A mechanically strong bond between hydroxyapatite- silica 
aerogel and natural bond can be achieved as silica-rich gel layers are formed on the surface of 
natural bone at implantation site [31,108]. By using the sol-gel technique, the particle size of 
hydroxyapatite-silica aerogel can be controlled either in micro or nano-size and thus the 
resorption rate of silicon can be tailored [109]. Besides that, silica aerogel can exist in the form 
of hydrophilic or hydrophobic depending on the presence of hydroxyl groups on its surface 
[111]. Because of this, the solubility problem of hydroxyapatite can be resolved by the bonding 
of this ceramic with silica aerogel frameworks [120]. Sol-gel technique is capable to overcome 
the difficulty of synthesized hydroxyapatite in aqueous solution as it is normally tends to 
incorporate impurities in the crystal lattice and grows into larger particles than those found in 
bone [121-122]. 
 
Revealing the interactions between hydroxyapatite-silica aerogel and cells will 
contribute to better understanding of various chemical and biochemical processes that occur 
when different synthesis conditions are applied. The fundamental understanding of the 
hydroxyapatite-silica aerogel interactions can help in improving the fabrication of 
hydroxyapatite-silica aerogel as a potential biomaterial with enhanced mechanical properties 
and biocompatibility performance. Hence, this enables new biomaterials with better activities 




This paper presents an inclusive review on the potential of hybrid silica aerogel in biomedical 
application. The vast number of available references shows that silica aerogel has a great 
application prospect in the development of modern biomaterial. In addition, the silica aerogels 
can be arranged and engineered to exhibit bioactive property similar to that of bioactive glasses. 
It can be synthesized at low temperature which could be beneficial for incorporating or 
encapsulating other bio-active agents and also suitable for bone substitution and drug delivery 
system. Thus, it drew the future perspectives on the ability of hydroxyapatite incorporated silica 




aerogel as a potential biomaterial. The incorporation of hydroxyapatite into silica aerogel 
tetrahedral networks via ambient colloidal sol-gel technique could improve the mechanical 
properties and biocompatibility performance. 
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